Overall, these data show that BMI-1 knockdown in H1975 cells affects tumorigenesis similarly to Unesbulin-mediated and PTC-028–mediated effects, supporting the hypothesis that BMI-1 pharmacologic inhibition achieved through these novel compounds inhibits tumor growth in a BMI-1–dependent manner. Here, BMI1 is linked to neoplasm.